[go: up one dir, main page]

WO1990005523A3 - Esters de phenanthrolinedicarboxylate, derives de 4-aminoquinoline et isoquinoline en tant qu'inhibiteurs de la transcriptase d'inversion de hiv - Google Patents

Esters de phenanthrolinedicarboxylate, derives de 4-aminoquinoline et isoquinoline en tant qu'inhibiteurs de la transcriptase d'inversion de hiv Download PDF

Info

Publication number
WO1990005523A3
WO1990005523A3 PCT/US1989/004774 US8904774W WO9005523A3 WO 1990005523 A3 WO1990005523 A3 WO 1990005523A3 US 8904774 W US8904774 W US 8904774W WO 9005523 A3 WO9005523 A3 WO 9005523A3
Authority
WO
WIPO (PCT)
Prior art keywords
phenanthrolinedicarboxylate
aminoquinoline
esters
inhibitors
reverse transcriptase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1989/004774
Other languages
English (en)
Other versions
WO1990005523A2 (fr
Inventor
Irene W Althaus
Fritz Reusser
William Gary Tarpley
Louis L Skaletzky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of WO1990005523A2 publication Critical patent/WO1990005523A2/fr
Publication of WO1990005523A3 publication Critical patent/WO1990005523A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Cette invention concerne une nouvelle utilisation médicale de certains esters de phénanthrolinedicarboxylate, de dérivés de 4-aminoquinoline et isoquinoline en tant que médicaments pour traiter des êtres humains atteints du virus d'immunodéficience humaine. Les composés ont les formules suivantes: (IA), (IB), (IC), (ID), dans lesquelles R, R1, R2, R', R'1, R'', R''1, R''2, R3, R4 et X sont définis dans la revendication 1.
PCT/US1989/004774 1988-11-15 1989-10-30 Esters de phenanthrolinedicarboxylate, derives de 4-aminoquinoline et isoquinoline en tant qu'inhibiteurs de la transcriptase d'inversion de hiv Ceased WO1990005523A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US27156788A 1988-11-15 1988-11-15
US271,567 1988-11-15
US27936488A 1988-12-02 1988-12-02
US279,364 1988-12-02
US28744888A 1988-12-20 1988-12-20
US287,448 1988-12-20

Publications (2)

Publication Number Publication Date
WO1990005523A2 WO1990005523A2 (fr) 1990-05-31
WO1990005523A3 true WO1990005523A3 (fr) 1990-07-12

Family

ID=27402391

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1989/004774 Ceased WO1990005523A2 (fr) 1988-11-15 1989-10-30 Esters de phenanthrolinedicarboxylate, derives de 4-aminoquinoline et isoquinoline en tant qu'inhibiteurs de la transcriptase d'inversion de hiv

Country Status (3)

Country Link
AU (1) AU4488989A (fr)
CA (1) CA2002414A1 (fr)
WO (1) WO1990005523A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3002700B2 (ja) * 1990-08-29 2000-01-24 化研生薬株式会社 抗エイズウイルス剤
AU1580492A (en) * 1991-03-14 1992-10-21 Upjohn Company, The Reissert compounds as anti-hiv agents
JPH06504791A (ja) * 1991-04-10 1994-06-02 オクタマー，インコーポレイティド レトロウィルス複製の阻害のための方法
DE4344452A1 (de) * 1993-12-24 1995-06-29 Hoechst Ag Aza-4-iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
DE69835430T2 (de) 1997-05-30 2007-03-08 Takeda Pharmaceutical Co. Ltd. Sulfonamidderivate, ihre herstellung und verwendung
CN1290254A (zh) 1998-02-05 2001-04-04 武田药品工业株式会社 氨磺酰衍生物及其制备和用途
CN108473435A (zh) 2015-10-05 2018-08-31 纽约市哥伦比亚大学理事会 自噬潮和磷脂酶d的活化剂以及包括tau的蛋白聚集体的清除和蛋白质病的治疗

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3790577A (en) * 1970-10-05 1974-02-05 Ici Ltd Pyridoquinoline dicarboxylic acid derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3790577A (en) * 1970-10-05 1974-02-05 Ici Ltd Pyridoquinoline dicarboxylic acid derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Chemical Abstracts, vol. 104, no. 11, 17 March 1986,(Columbus, Ohio, US), Z. Szulc et al: "The syntheses and properties of tricyclic azines as potential interferon inducers and antivirus agents", see page 650, abstract 88460z, & Stud. Org. Chem. (Amsterdam) 1984, 18 (Bio-Org. Heterocycl.), 363-6 *

Also Published As

Publication number Publication date
CA2002414A1 (fr) 1990-05-15
WO1990005523A2 (fr) 1990-05-31
AU4488989A (en) 1990-06-12

Similar Documents

Publication Publication Date Title
AU2452288A (en) Nucleoside derivatives useful in treating retroviral infections
MX9203543A (es) Medicamento.
ES2130114T3 (es) 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infeccion por hiv.
GR3017128T3 (en) Treatment of hiv infections and compounds useful therein.
AU1968992A (en) Preparation of fatty acid medicaments
IE873245L (en) Administering a deoxythymidine
DK284189D0 (da) Farmaceutisk produkter
GR3017242T3 (en) Use of trifluoromethyl phenyl-tetrahydropyridines in the manufacture of a medicament for the treatment of anxio-depressive disorders.
CA2179015A1 (fr) Utilisation de bis(amidinobenzimidazoles) dans la fabrication de medicaments destines a inhiber l'integrase retrovirale
UA19756A1 (uk) Спосіб одержаhhя піперазиhілалкіл-3(2h)піридазиhоhів або їх фармацевтичhо прийhятих солей
WO1990005523A3 (fr) Esters de phenanthrolinedicarboxylate, derives de 4-aminoquinoline et isoquinoline en tant qu'inhibiteurs de la transcriptase d'inversion de hiv
EP0328924A3 (fr) Composés de thiénotriazolodiazépine et ses applications pharmaceutiques
RU94045248A (ru) Способ ингибирования активности вируса иммунодефицита человека (hiv) in vivo
EP0338415A3 (fr) Utilisation de sulfonylurées dans le traitement de l'oedème
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
ATE159427T1 (de) Anwendung des n-n-butyl-derivates von desoxynojirimycin zur herstellung eines arzneimittels zur inhibierung von hiv-virus
WO2000043014A3 (fr) MUTATIONS DE VIH-1 SELECTIONNEES A L'AIDE DE β-2',3'-DIDEHYDRO-2',3'-DIDEOXY-5-FLUOROCYTIDINE
WO1997026880A3 (fr) Utilisation d'une combinaison de delavirdine et d'un ou plusieurs inhibiteurs de protease chez des patients contamines par le vih-1
WO1986006960A3 (fr) Utilisation de nicorandile ou de pinacidile dans le traitement de maladies vasculaires peripheriques
FI952018L (fi) BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskriptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon
NZ269990A (en) Inhibiting hiv viruses; use of azaspirane compounds in preparation of medicaments
FI871479A0 (fi) Menetelmä lääkeaineina käyttökelpoisten perhydrotiatsepiini- ja perhydroatsepiinijohdannaisten valmistamiseksi
EP1731155A3 (fr) Beta-d-2', 3' -didehydro-2', 3' -dideoxy-5-fluorocytidine pour l'utilisation dans le traitement d'une infection par le hiv
AU2880495A (en) Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
DK0457336T3 (da) Ny anvendelse af 4-carbamoyl-1-beta-D-ribofuranosylimidazolium-5-olat

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 1989912025

Country of ref document: EP

AK Designated states

Kind code of ref document: A2

Designated state(s): AU DK FI HU JP KR NO SU US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE FR GB IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU DK FI HU JP KR NO SU US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWW Wipo information: withdrawn in national office

Ref document number: 1989912025

Country of ref document: EP